IRVING, Texas, February 5, 2025 - McKesson Corporation (NYSE:MCK) today announced results for the third quarter ended December 31, 2024. Third Quarter Highlights: . Consolidated …

McKesson's broad set of specialty solutions, the financial results we consolidated with the McKesson's US Pharmaceutical segment. Upon closing, PRISM is anticipated to be …

5 days ago · McKesson (NYSE: MCK) Q3 2025 Earnings Call Feb 05, 2025, 4:30 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants. Prepared Remarks: …

4 days ago · McKesson Corp reported strong third-quarter results with an 18% increase in revenue to $95.3 billion and a 16% growth in adjusted operating profit to $1.5 billion.

5 days ago · McKesson Q3 2025 Earnings Call Feb 05, 2025, 4: 30 p.m ... Prepared Remarks: Operator. Please stand by. Welcome to McKesson's third quarter fiscal 2025earnings …

McKesson Corporation (NYSE:MCK) Q3 2025 Earnings Call Transcript February 5, 2025 Operator: Welcome to McKesson’s Third Quarter Fiscal 2025 Earnings Conference Call. …

4 days ago · McKesson Corporation, Q3 2025 Earnings Call, Feb 05, 2025 Feb. 05 McKesson Narrows FY 2025 EPS View to $32.55-$32.95, vs Prior Guidance of $32.40-$33 and FactSet …

4 days ago · McKesson Corporation is a global leader in healthcare and dedicated to improving care in every setting — one product, one partner, one patient at a time. We partner with care …

McKesson Corporation. (NYSE:MCK) Q3 2025 Earnings Conference Call February 5, 2025 4:30 PM ETCompany ParticipantsRachel Rodriguez - VP of Investor...

5 days ago · On February 5, 2025, McKesson Corp (MCK, Financial) released its 8-K filing for the third quarter of fiscal 2025, ending December 31, 2024. McKesson, a leading pharmaceutical …